Anna Aldea

Heterogeneity among patients with tumor necrosis factor receptor–associated periodic syndrome phenotypes

Ebun Aganna, L Hammond, Philip N. Hawkins et al. · Arthritis & Rheumatism · 2003 · 194 citations

Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the <i>CIAS1/PYPAF1/NALP3</i> gene

Juan I. Aróstegui, Anna Aldea, Consuelo Modesto et al. · Arthritis & Rheumatism · 2004 · 98 citations

A severe autosomal‐dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the <i>MEFV</i> H478Y variant in a Spanish kindred: An unusual familial Mediterranean fever phenotype or another <i>MEFV</i>‐associated periodic inflammatory disorder?

Anna Aldea, Josep M. Campistol, Juan I. Aróstegui et al. · American Journal of Medical Genetics Part A · 2003 · 89 citations

Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response

Juan I. Aróstegui, P Solís, Anna Aldea et al. · European Journal of Pediatrics · 2004 · 55 citations

Inflammation, Colchicine Treatment, Anti-inflammatory +8

Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19

Carolina García‐Vidal, Rodrigo Alonso, Ana M. Camon et al. · Journal of Antimicrobial Chemotherapy · 2021 · 51 citations · Full text